Breaking News Instant updates and real-time market news.

ABUS

Arbutus Biopharma

$2.65

-0.05 (-1.85%)

, ARWR

Arrowhead

$4.39

-0.07 (-1.57%)

07:50
11/30/16
11/30
07:50
11/30/16
07:50

Arbutus Biopharma upgraded on competitor withdrawal at Chardan

As noted earlier, Chardan upgraded Arbutus (ABUS) to Buy from Neutral. Analyst Gbola Amusa upgraded the stock after Arrowhead (ARWR) announced that it was terminating its intravenously delivered RNAi clinical programs ARC-520, ARC-521, and ARC-AAT. The analyst now expects Arbutus' share of the HBV RNAi to rise to 47.5% from 17.5%. Amusa does not expect Arbutus' treatments to cause the same safety problems as those of Arrowhead. Amusa is upbeat on Arbutus' lead asset, ARB-1467. Target to $4 from $3.

ABUS

Arbutus Biopharma

$2.65

-0.05 (-1.85%)

ARWR

Arrowhead

$4.39

-0.07 (-1.57%)

  • 30

    Nov

  • 06

    Dec

ABUS Arbutus Biopharma
$2.65

-0.05 (-1.85%)

10/06/16
RBCM
10/06/16
NO CHANGE
RBCM
Alnylam news not a negative read through on other RNAi drugs, says RBC Capital
After Alnylam (ALNY) announced that it was discontinuing one of its Phase III RNAi drugs due to poor clinical outcomes, RBC Capital analyst Michael Yee does not thinks that the news indicates problems with all RNAi drugs. Rather, he thinks that RNAi was not the proper treatment for the disease that Alnylam was targeting. Other companies with RNAi treatments include The Medicines Company (MDCO0, Ionis Pharmaceuticals (IONS), Arrowhead (ARWR), and Arbutus Biopharma (ABUS).
10/14/16
CHDN
10/14/16
UPGRADE
CHDN
Neutral
Arbutus Biopharma upgraded to Neutral from Sell at Chardan
10/14/16
10/14/16
UPGRADE

Neutral
Arbutus Biopharma upgraded to Neutral on valuation at Chardan
As previously reported, Chardan upgraded Arbutus Biopharma to Neutral from Sell. Analyst MadhuKumar upgraded shares citing relative shares underperformance ahead of Q4 and 2017 clinical catalyst in the Phase IIa study of ARB-1467.
11/30/16
CHDN
11/30/16
UPGRADE
CHDN
Buy
Arbutus Biopharma upgraded to Buy from Neutral at Chardan
ARWR Arrowhead
$4.39

-0.07 (-1.57%)

11/30/16
CHDN
11/30/16
DOWNGRADE
CHDN
Neutral
Arrowhead downgraded to Neutral from Buy at Chardan
Chardan downgraded Arrowhead to Neutral and lowered its price target to $2 from $8 following the surprise announcement of its discontinuation of three clinical programs: ARC-520, ARC-521, and ARC-AAT.
11/30/16
CANT
11/30/16
DOWNGRADE
CANT
Hold
Arrowhead downgraded to Hold from Buy at Cantor
11/30/16
CANT
11/30/16
DOWNGRADE
CANT
Hold
Arrowhead downgraded on elimination of program at Cantor
As noted earlier, Cantor downgraded Arrowhead to Hold from Buy. Analyst Elemer Piros downgraded the stock after the company announced that it was terminating its intravenously delivered RNAi clinical programs ARC-520, ARC-521, and ARC-AAT but pursuing its subcutaneously delivered candidates. The analyst says that the subcutaneously delivered candidates are in early stages of development and lack visibility. Target to $1 from $15.
11/30/16
WBLR
11/30/16
DOWNGRADE
WBLR
Market Perform
Arrowhead downgraded to Market Perform from Outperform at William Blair

TODAY'S FREE FLY STORIES

UAL

United Continental

$77.97

1.1 (1.43%)

16:42
01/23/18
01/23
16:42
01/23/18
16:42
Hot Stocks
United Continental says 2017 a 'transition' year »

Says understands that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 21

    Mar

AUO

AU Optronics

$4.69

0.03 (0.64%)

16:42
01/23/18
01/23
16:42
01/23/18
16:42
Upgrade
AU Optronics rating change  »

AU Optronics upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGII

Argo Group

$65.10

0.05 (0.08%)

16:41
01/23/18
01/23
16:41
01/23/18
16:41
Hot Stocks
Argo Group reports preliminary pre-tax catastrophe loss of $34M-$38M in Q4 »

Argo Group International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGNX

MacroGenics

$20.25

0.83 (4.27%)

16:40
01/23/18
01/23
16:40
01/23/18
16:40
Hot Stocks
MacroGenics completes interim futility analysis of the Phase 3 SOPHIA trial »

MacroGenicsannounced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPL

LG Display

$15.59

1.33 (9.33%)

16:38
01/23/18
01/23
16:38
01/23/18
16:38
Upgrade
LG Display rating change  »

LG Display upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDS

GDS Holdings

$26.75

-0.22 (-0.82%)

16:37
01/23/18
01/23
16:37
01/23/18
16:37
Syndicate
Breaking Syndicate news story on GDS Holdings »

GDS Holdings files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:36
01/23/18
01/23
16:36
01/23/18
16:36
General news
API crude inventories for week of January 19 »

API reports that crude…

NAVI

Navient

$13.44

-0.08 (-0.59%)

16:34
01/23/18
01/23
16:34
01/23/18
16:34
Earnings
Breaking Earnings news story on Navient »

Navient reports Q4 GAAP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FHN

First Horizon

$20.11

0.01 (0.05%)

16:34
01/23/18
01/23
16:34
01/23/18
16:34
Hot Stocks
First Horizon replaces share repurchase program »

The board of First…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FHN

First Horizon

$20.11

0.01 (0.05%)

16:33
01/23/18
01/23
16:33
01/23/18
16:33
Hot Stocks
First Horizon increases quarterly dividend 33% »

First Horizon National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SD

SandRidge Energy

$19.29

-0.02 (-0.10%)

16:32
01/23/18
01/23
16:32
01/23/18
16:32
Hot Stocks
SandRidge Energy: Not in best interests of holders to accept Ichan's proposal »

SandRidge Energy issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CQP

Cheniere Energy Partners

$31.30

0.41 (1.33%)

16:32
01/23/18
01/23
16:32
01/23/18
16:32
Hot Stocks
Cheniere Energy Partners raises dividend to 50c from 44c »

Cheniere Energy Partners,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

GORO

Gold Resource

$4.97

0.05 (1.02%)

16:32
01/23/18
01/23
16:32
01/23/18
16:32
Hot Stocks
Gold Resource to expand Arista Mine vein system »

Gold Resource announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

TRMK

Trustmark

$33.53

-0.03 (-0.09%)

16:31
01/23/18
01/23
16:31
01/23/18
16:31
Earnings
Trustmark reports Q4 adjusted EPS 48c, consensus 47c »

Gerard R. Host, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

16:30
01/23/18
01/23
16:30
01/23/18
16:30
Options
Preliminary option volume of 22.5M today »

Preliminary option volume…

SBBP

Strongbridge Biopharma

$8.70

0.25 (2.96%)

16:27
01/23/18
01/23
16:27
01/23/18
16:27
Syndicate
Strongbridge Biopharma files to sell 5M shares of common stock »

JMP Securities is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$120.00

0.56 (0.47%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Technical Analysis
Technical Take: Texas Instruments drops sharply after results »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Hot Stocks
Breaking Hot Stocks news story on Capital One »

Capital One reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

JAX

J. Alexander's

$10.20

-0.3 (-2.86%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Hot Stocks
J. Alexander's major holders support 99 Restaurants acquisition »

Substantial holders of J.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

TK

Teekay Corp.

$10.74

0.05 (0.47%)

16:25
01/23/18
01/23
16:25
01/23/18
16:25
Syndicate
Teekay Corp. 10M share Spot Secondary; price range $9.75-$10.00 »

Morgan Stanley,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COF

Capital One

$105.71

0.22 (0.21%)

16:25
01/23/18
01/23
16:25
01/23/18
16:25
Hot Stocks
Breaking Hot Stocks news story on Capital One »

Capital One reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ROL

Rollins

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Hot Stocks
Rollins raises dividend 21.7% to 14c »

Rollins approved a 21.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

VLO

Valero

$98.69

-0.26 (-0.26%)

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Hot Stocks
Valero announces additional $2.5B share repurchase authorization »

The board of Valero…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

CMRE

Costamare

$6.16

-0.12 (-1.91%)

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Earnings
Costamare reports Q4 EPS 17c, consensus 15c »

On January 23, 2018,the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:22
01/23/18
01/23
16:22
01/23/18
16:22
Hot Stocks
Capital One reports Q4 net interest margin 7.03%, down 5 bps »

Reports Efficiency ratio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.